RELATED ARTICLES
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Taishiro Chikamori
JAMA. 2003;289(16):2066.
EXTRACT
| FULL TEXT
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Jan Laws Houghton
JAMA. 2003;289(16):2066.
EXTRACT
| FULL TEXT
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Christopher R. Palmer, Morris J. Brown, Giuseppe Mancia, and Luis M. Ruilope
JAMA. 2003;289(16):2066-2067.
EXTRACT
| FULL TEXT
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Franz H. Messerli and Michael A. Weber
JAMA. 2003;289(16):2067-2068.
EXTRACT
| FULL TEXT
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
H. T. Ong
JAMA. 2003;289(16):2068.
EXTRACT
| FULL TEXT
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Steven A. Yarows
JAMA. 2003;289(16):2068-2069.
EXTRACT
| FULL TEXT
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme InhibitorsReply
Jackson T. Wright, Jr, Barry R. Davis, and Jeffrey A. Cutler
JAMA. 2003;289(16):2069-2070.
EXTRACT
| FULL TEXT
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
JAMA. 2002;288(23):2981-2997.
ABSTRACT
| FULL TEXT